In the rapidly evolving landscape of biotechnology and medical research, laboratory animal models, 3D cultures, and organoids are redefining the boundaries of scientific innovation. These technologies are not merely tools; they are the foundation of groundbreaking discoveries, from understanding disease mechanisms to advancing personalized medicine.
According to BCC Research, the global market for laboratory animal models, 3D cultures, and organoids is ready for significant growth in the coming years. With a projected compound annual growth rate (CAGR) of 12.5% from 2024 to 2029, the market is expected to reach $5.0 billion by the end of the forecast period. This growth is fueled by several key factors, including increased funding for research and development, rising demand for more predictive models in drug discovery, and the expanding applications of these technologies in various fields.